Ahmad Bani-Jaber

Ahmad Bani-Jaber

Auto-generated profile, based on publicly available information

Ahmad Bani-Jaber

Department of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, The University of Jordan, Amman, Jordan

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2007 in Food and Bioproducts Processing
Verified
Journal Article
Closed access
PDF file
ODO. Abu Diak
O. Abu Diak
ABA. Bani-Jaber
A. Bani-Jaber
BAB. Amro
B. Amro
DJD. Jones
D. Jones
GAGavin Andrews
Gavin Andrews

8 February 2011 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
ABAhmad Bani-Jaber
Ahmad Bani-Jaber
LALeena Al-Aani
Leena Al-Aani
HAHatim S AlKhatib
Hatim S AlKhatib
BABashar Al-Khalidi
Bashar Al-Khalidi

25 February 2020 in Pharmaceutical Development and Technology
Verified
Journal Article
Closed access
ABAhmad Bani-Jaber
Ahmad Bani-Jaber
SASamaa Abdullah
Samaa Abdullah
The aim was to develop sustained-release aqueous suspensions of ambroxol utilizing drug-polymer complexation and raft-forming formulations. Ambroxol-carrageenan (ABX-CRG) complexation was studied for the optimum binding capacity, which was used to prepare the complex by kneading and co-precipitation. The prepared complex was characterized by Fourier transform infrared spectroscopy, differential scanning calorimetry and powder X-ray diffractometry. The complex was formulated as suspensions in aqueous raft-forming vehicle of sodium alginate (NA) and calcium carbonate (CC). The suspensions differed in the molecular weight and concentration of NA, in addition to CC level and inclusion of CRG in excess of drug-polymer complexation. In 0.1 M HCl as simulated gastric fluid, the suspensions were observed for their ability to form rafts and studied for drug-release. The optimum sustained-release, raft forming and pourable formulation using high molecular weight NA, NA concentration of 18 mg/ml and CC concentration of 9 mg/ml was reached. Another optimum suspension was obtained by replacement of CC with excess CRG. However, pH dissolution profiles of the optimum suspensions revealed less pH sensitivity of the release consequent to these replacements well as more stable ABX release upon aging. Relative to Gaviscon liquid, the optimum suspensions formed rafts of similar strength and higher resilience.

30 November 2021 in Gels
Verified
Journal Article
Open access
PDF file
Shadab MDShadab MD
Shadab MD
SASamaa T. Abdullah
Samaa T. Abdullah
NANabil A. Alhakamy
Nabil A. Alhakamy
ABAhmad Bani-Jaber
Ahmad Bani-Jaber
ARAmmu Kutty Radhakrishnan
Ammu Kutty Radhakrishnan
WRWaleed Y. Rizg
Waleed Y. Rizg
This study aimed to develop gastro-retentive sustained-release ambroxol (ABX) nanosuspensions utilizing ambroxol-kappa-carrageenan (ABX-CRGK) complexation formulations. The complex was characterized by differential scanning calorimetry, powder x-ray diffractometer, and scanning electron microscopy. The prepared co-precipitate complex was used for the development of the sustained-release formulation to overcome the high metabolic and poor solubility problems associated with ABX. Furthermore, the co-precipitate complex was formulated as a suspension in an aqueous floating gel-forming vehicle of sodium alginate with chitosan, which might be beneficial for targeting the stomach as a good absorption site for ABX. The suspension exhibited rapid floating gel behaviour for more than 8 h, thus confirming the gastro-retentive effects. Particle size analysis revealed that the optimum nanosuspension (ABX-NS) had a mean particle size of 332.3 nm. Afterward, the ABX released by the nanoparticles would be distributed to the pulmonary tissue as previously described. Based on extensive pulmonary distribution, the developed nanosuspension-released ABX nanoparticles showed significant cytotoxic enhancement compared to free ABX in A549 lung cancer cells. However, a significant loss of mitochondrial membrane potential (MMP) also occurred. The level of caspase-3 was the highest in the ABX-NS-released particle-treated samples, with a value of 416.6 ± 9.11 pg/mL. Meanwhile, the levels of nuclear factor kappa beta, interleukins 6 and 1 beta, and tumour necrosis alpha (NF-kB, IL-6, IL-1β, and TNF-α, respectively) were lower for ABX-NS compared to free ABX (p < 0.05). In caspase-3, Bax, and p53, levels significantly increased in the presence of ABX-NS compared to free ABX. Overall, ABX-NS produced an enhancement of the anticancer effects of ABX on the A549 cells, and the developed sustained-release gel was successful in providing a gastro-retentive effect.

17 October 2016 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
ABAhmad Bani-Jaber
Ahmad Bani-Jaber
IAIyad Alshawabkeh
Iyad Alshawabkeh
SASamaa Abdullah
Samaa Abdullah
IHImad Hamdan
Imad Hamdan
AAAdel Ardakani
Adel Ardakani
MHMaha Habash
Maha Habash

1 January 2011 in Chemical and Pharmaceutical Bulletin
Verified
Journal Article
Open access
PDF file
ABAhmad Khaled Bani-Jaber
Ahmad Khaled Bani-Jaber
MAMahmoud Y. Alkawareek
Mahmoud Y. Alkawareek
JAJozef Jawad Al-Gousous
Jozef Jawad Al-Gousous
AAAhmad Y Abuhelwa
Ahmad Y Abuhelwa
The aim of this study was to evaluate the influence of Na-bicarbonate as an effervescent agent on the floating and sustained-release characteristics in 0.1 M HCl of tablets made of Eudragit E PO (EE) and/or Eudragit L-100-55 (EL) as matrix formers at different EE : EL weight ratios: 0 : 100, 25 : 75, 50 : 50, 75 : 25, and 100 : 0. The tablets were made by direct compression utilizing metronidazole as a model drug. Effervescent tablets with 50EE/50EL (w/w) showed the best floating and sustained drug release properties in the dissolution medium. The corresponding noneffervescent tablets were nonfloating and showed significantly faster drug release. Effervescent tablets with single polymers showed an immediate drug release pattern. These results were explained by Fourier-transform infrared spectroscopy and elemental analysis, which showed strong evidence of interpolyelectrolyte complexation between EE and EL when they were exposed to 0.1 M HCl as an effervescent hybrid matrix, but not as a noneffervescent hybrid matrix. The role of Na-bicarbonate in allowing EE–EL complexation during dissolution was explained as due to raising the pH around EL particles for sufficient polymer ionization and ionic-interaction with the ionized EE.